BDB562495

CD49f Rat anti-Human, PerCP-Cy5.5, Clone: GoH3, BD

Manufacturer: Fischer Scientific

Select a Size

Pack Size SKU Availability Price
Each of 1 BDB562495-Each-of-1 In Stock ₹ 16,198.00

BDB562495 - Each of 1

₹ 16,198.00

In Stock

Quantity

1

Base Price: ₹ 16,198.00

GST (18%): ₹ 2,915.64

Total Price: ₹ 19,113.64

Antigen

CD49f

Classification

Monoclonal

Conjugate

PerCP-Cyanine5.5

Formulation

Aqueous buffered solution containing BSA and ≤0.09% sodium azide.

Immunogen

Mouse mammary tumor cells

Quantity

25 Tests

Primary or Secondary

Primary

Content And Storage

Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze.

Applications

Flow Cytometry

Clone

GoH3

Description

ITGA6; IThe GoH3 monoclonal ntegrin alpha-6; Integrin α6 chain; VLA-6; ITA6

Host Species

Rat

Purification Method

Affinity Purified

Regulatory Status

RUO

Target Species

Human

Isotype

IgG2a κ

Related Products

Img

Fischer Scientific

BDB562475

--

Img

Fischer Scientific

BDB561924

--

Img

Fischer Scientific

BDB561958

--

Img

Fischer Scientific

BDB562334

--

Img

Fischer Scientific

BDB562335

--

Img

Fischer Scientific

BDB563718

--

Img

Fischer Scientific

3969576

Mouse Monoclonal Antibody...

Img

Fischer Scientific

BDB562068

--

Description

  • The GoH3 monoclonal antibody specifically binds to CD49f which is also known as integrin α6 chain
  • CD49f is a ∽150 kDa type I transmembrane glycoprotein that belongs to the integrin alpha chain family of extracellular matrix and cell adhesion receptors
  • The integrin α6 subunit associates with the integrin β1 chain (CD29) to form VLA-6 and with the integrin β4 chain (CD104) to form the integrin α6β4 complex, also known as the laminin and kalinin receptor
  • CD49f is expressed mainly on T cells, monocytes, platelets, epithelial cells, endothelial cells, perineural cells, and trophoblasts of placenta
  • GoH3 recognizes an extracellular epitope of integrin α6 on human, mouse and bovine cells
  • GoH3 has been reported to block the binding of integrin α6 to laminin P1 and E8 fragments.